Endovascular Management of Vascular Complications in Ehlers-Danlos Syndrome Type IV.
Mubarak AlqahtaniAmandine ClaudinotMarine GaudryAxel BartoliPierre Antoine BarralVincent VidalLouis BoyerTiffany BusaFarah CadourAlexis JacquierMariangela De MasiLaurence BalPublished in: Journal of clinical medicine (2022)
(1) Background: The vascular type of Ehlers-Danlos syndrome (vEDS) is a rare genetic connective tissue disorder caused by pathogenic variants in the COL3A1 gene that result in arterial and organ fragility and premature death. We present five cases of vEDS that highlight the diagnosis and treatment challenges encountered by clinicians with these patients. (2) Case presentations: we present the cases of five patients with vascular complications of vEDS who were successfully managed using endovascular interventions or hybrid techniques at our institution from 2005 to 2022. (3) Conclusions: These data emphasize that a multidisciplinary approach is needed for vEDS patients and that when endovascular or hybrid treatment is performed in a timely manner by a skilled team of interventional radiologists, good results can be achieved. Our report also demonstrates that the prognosis of vEDS patients has improved over the past 20 years with a new prevention program including celiprolol therapy, physical activity adaptation and limitation, and scheduled monitoring by expert clinicians.
Keyphrases
- end stage renal disease
- physical activity
- chronic kidney disease
- newly diagnosed
- ejection fraction
- palliative care
- stem cells
- gene expression
- risk factors
- body mass index
- patient reported outcomes
- quality improvement
- machine learning
- dna methylation
- genome wide
- electronic health record
- artificial intelligence
- transcription factor